Skip to main content
OpenTrials
Completed

NCT Number: NCT01530685

Gycabiane and Glycemic Control of Prediabetic Subjects

The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Pitié Salpetriere

Paris, 75013, France

About this study

Cinnamon's effects on blood glucose have been the subject of many clinical and animal studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in people with prediabetes still remains unclear.

The main purpose of this study is to examine the effects of supplementation with Glycabiane, a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight prediabetic subjects in a randomized, placebo-controlled, clinical trial.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female from 25 to 65 years old
  • 1.0g/L ≤ fast blood glucose < 1.26g/L
  • overweight (IMC > 25)

Exclusion criteria

  • thyroid disease
  • hypogonadism
  • History of musculoskeletal, autoimmune or neurological disease
  • Treatment against thyroid disease, hypoglycemia, hypertension, or anti-coagulant
  • Pregnant or lactating women

Treatment and study plan

Glycabiane

Dietary Supplement

2 gelule per day for 4 months

Other names: Dietary supplement

Placebo

Dietary Supplement

2 gelules per day for 4 months

Primary outcomes

  1. Fast Blood Glucose

    Time frame: 4 months

    Fast blood glucose will be measured before and after 4 months of supplementation and after 2 months of wash-out

Sponsors and collaborators

Lead sponsor

PiLeJe

Industry

Registry information

Official study title

Effect of Glycabiane, a Dietary Supplement, on Glycemic Control of Prediabetic Subjects

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Feb 10, 2012
Registry last updated
Apr 20, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.